Redmile Group’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History

Redmile Group’s Portfolio AYLA Stock Details AYLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-341,030	Closed	-$372K	–	77
2022 Q2	$372K	Sell	341,030 -108,701	-24%	-$248K	0.01%	71
2022 Q1	$1.79M	Sell	449,731 -218,085	-33%	-$1.13M	0.06%	67
2021 Q4	$5.68M	Hold	667,816	–	–	0.13%	64
2021 Q3	$7.57M	Hold	667,816	–	–	0.13%	68
2021 Q2	$6.8M	Hold	667,816	–	–	0.1%	76
2021 Q1	$7.29M	Hold	667,816	–	–	0.1%	78
2020 Q4	$7.61M	Buy	667,816 +1,150	+0.2%	+$13.3K	0.09%	74
2020 Q3	$7.85M	Hold	666,666	–	–	0.14%	72
2020 Q2	$6.69M	Buy	+666,666	New	+$9.26M	0.12%	71

Other funds holding AYLA

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

CSS LLC Chicago, Illinois $1.8B AUM 59.56% 1-Year Est. Return

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return

Balyasny Asset Management

Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return

Susquehanna International Group

Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return